Aktuell Dec 06, 2021 Roche-Tests können Omikron erkennen Die Roche-Tochter TIB Molbiol hat neue Corona-Tests entwickelt, die auch die neue Omikron-Variante erkennen können. Diese Tests sollen der Forsch...
News Dec 06, 2021 Roche tests able to detect Omicron The Roche subsidiary TIB Molbiol has developed new coronavirus testing kits that can also detect the new Omicron variant of the disease. These te...
News Jan 20, 2021 Swiss PharmaCan successfully tests anti-COVID drug Swiss PharmaCan and Australia-based MGC Pharma have successfully concluded phase II clinical testing for their COVID-19 therapeutic candidate, Ar...
Aktuell Aug 25, 2020 Bloom Diagnostics erhält Kapital für COVID-19-Antikörpertests Das intelligente Diagnosesystem von Bloom Diagnostics soll COVID-19-Antikörpertests für alle zugänglich machen. Für die Markteinführung des nur z...
News Aug 25, 2020 Bloom Diagnostics raises capital for COVID-19 antibody tests The smart diagnosis system developed by Bloom Diagnostics is set to make COVID-19 antibody testing accessible to all. The test process takes just...
Aktuell Jan 20, 2021 Swiss PharmaCan testet Anti-COVID-Medikament erfolgreich Swiss PharmaCan und die australische MGC Pharma haben die klinischen Phase II-Tests für ihren COVID-19-Therapiekandidaten ArtemiC erfolgreich abg...
Aktuell Sep 07, 2020 Roche testet gleichzeitig auf Corona und Grippe Die amerikanische Zulassungsbehörde erlaubt dem Basler Life Sciences-Konzern Roche, einen Test einzusetzen, mit dem gleichzeitig eine Corona- und...
News Sep 07, 2020 Roche testing for coronavirus and flu simultaneously The U.S. Food and Drug Administration has given the Basel-based life sciences company Roche authorization to use a test that simultaneously tests...
Success stories May 25, 2023 CSL Behring: “The deciding factors were time to market and the proven track record of the Bern site.” CSL Behring For over a century, CSL Behring (CSLB) has kept its founding promise to help patients suffering from rare and serious diseases. It specializes in...
Third Party Event Webinar COVID-19: Challenges and Opportunities in Brazil and Mexico for Swiss Business
News Sep 16, 2020 Lonza set to manufacture coronavirus drug for Humanigen The Basel-based pharmaceutical supplier Lonza is supporting the US firm Humanigen in the development of a potential coronavirus therapeutic. Lonz...
Success stories Jul 18, 2018 Biokema conquers China one step at a time "China is forcing us to do things differently." Florence Cousté-Bémer, Head of International Activities at Biokema SA, a veterinary pharmaceutica...
News Aug 21, 2020 Researchers develop novel approach against the coronavirus The Swiss National Science Foundation is funding a novel approach for a coronavirus vaccine. This approach developed by virologist Cornel Fraefel...